UBS AG Logo
Login | Preferences | Contact |engita
UBS Fund Gate - Luxembourg
   
Home
News
Products
Compare products
Virtual portfolios
E-mail subscription
General information
 
 
Search for products
Overview
Search by criteria
Product information
Print "Daily Fact Sheet"Print version as PDF file format
UBS products  ›  Product information
UBS (Lux) Key Selection SICAV - Global Multi Income (USD) (HKD) P-mdist
ISIN no.:  LU1224420122
PDF
PDF
PDF
PDF
Overview  
Category profile
The innovative strategy of UBS Multi Asset Income Funds focuses on income generation from different sources while aiming to keep capital volatility low. Investments are well diversified across investment-grade, high-yield and index-linked bonds, equities, and real estate (REITs) and the portfolios actively managed for an efficient risk-return profile.

Fund description
The fund is focused on generating income with the opportunity for capital growth over a market cycle.
It is globally diversified across a broad range of complementary asset classes to tap different sources of income while mitigating risks.
It is actively managed to flexibly navigate different market environments.
The exchange rate risk between USD and HKD is not hedged.
This share class (mdist) may make monthly, gross-of-fee distributions. The distributions are not directly linked to any capital gain or income generated by the fund. This share class may distribute capital as well as income. There are potential negative tax consequences for some investors in some jurisdictions. This share class must not be seen as an alternative to a savings account or interest paying investments.

Key benefits
Investors can expect an attractive and regular stream of income.
Investors can seize global income opportunities across traditional and opportunistic asset classes.
Investors can rely on an experienced portfolio management team with a proven track record that draws upon the full breadth of UBS's global resources in asset allocation, security selection, structured solutions and comprehensive risk management.

Risks
The fund invests in equities and fixed income instruments globally, as well as in alternative forms of investment. It may therefore be subject to fluctuations in value. The fund may use derivatives which can reduce investment risk or give rise to additional risks such as counterparty risk. The fund can invest in less liquid assets that may be difficult to sell in the case of distressed markets. It therefore cannot be ruled out that the daily issue and redemption of fund units may be suspended temporarily. The value of a unit may fall below the purchase price. This requires an elevated risk tolerance and capacity. Every fund reveals specific risks, a description of these risks can be found in the prospectus. This share class (mdist) may make monthly, gross-of-fee distributions. As a consequence, in addition to income, this share class may also distribute capital. This can have negative tax consequences for investors in some jurisdictions. Investors should seek their own tax advice.

Product features
Product type
Open end
Product category
UBS Asset Allocation Funds
UBS Multi Asset Income Funds
Product domicile
Luxembourg
Portfolio management
UBS Asset Management
Fund management
UBS Fund Management (Luxembourg) S.A.
Custodian bank
UBS Europe SE, Luxembourg Branch
Day of inception
May 29, 2015
Currency of account
HKD
Close of financial year
September 30
Issue / redemption
daily
Management fee
1.34% p.a.
Total expense ratio (TER)
1.83% p.a.
Swing pricing
yes

Current data
Net asset value
HKD995.71
17/10/2017
High - last 12 months
HKD997.65
13/10/2017
Low - last 12 months
HKD925.85
15/11/2016
Last distribution
HKD4.11
19/10/2017
Assets of the unit class in mn
HKD44.97
17/10/2017
Total product assets in mn
HKD778.74
17/10/2017

Symbols
ISIN no.
LU1224420122
Bloomberg Ticker
UBSMIPI LX

 
Performance chart (HKD-based, as of October 17, 2017)
Indexed, Month-end values
Performance chart (HKD-based, as of October 17, 2017)


Performance (in %, as of October 17, 2017)
in %
1
year
3
years
5
years
since
29/05/2015
HKD
10.12
-
-
11.94
These figures refer to the past. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units.

By the 10 largest equity positions (in %, as of September 29, 2017)
Altria Group Inc
0.77
Procter & Gamble Co/The
0.76
Johnson & Johnson
0.75
Sanofi
0.67
Taiwan Semiconductor Manufacturing Co Ltd
0.62

By investment instrument (in %, as of September 29, 2017)
Chart
For marketing and information purposes by UBS. UBS funds under Luxembourg law. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS Fund Services (Luxembourg) S.A., P.O. Box 91, L-2010 Luxembourg or from UBS Europe SE, Luxembourg Branch, P.O. Box 2, L-2010 Luxembourg. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management
Source for all data and charts (if not indicated otherwise): UBS Asset Management
No responsibility is taken for the correctness of the information provided above.

Important legal information - please read the disclaimer before proceeding.
Products and services in these web pages may not be available for residents of certain nations.
Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2017. All rights reserved.
Privacy Policy